Karyopharm Therapeutics, Inc. (KPTI)

10.09 +0.02 (+0.20%) USD  |  NASDAQ  |  Feb 25, 16:00
10.10 +0.01 (+0.10%) After-Hours: 20:00
More

Karyopharm Therapeutics Stock Based Compensation (Annual)

Stock Based Compensation (Annual) Chart

View Stock Based Compensation (Annual) for KPTI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Based Compensation (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Stock Based Compensation (Annual) Range, Past 5 Years

View Stock Based Compensation (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Based Compensation (Annual) Benchmarks

View Stock Based Compensation (Annual) Benchmarks
Start Trial
Alnylam Pharmaceuticals, Inc. Upgrade
Baxter International, Inc. Upgrade
Bruker Corp. --
Catalyst Pharmaceuticals, Inc. Upgrade
Agios Pharmaceuticals, Inc. Upgrade